Bayer begins $240m AI drug discovery project with Exscientia

Germany-based Bayer is collaborating with Exscientia, an artificial intelligence (AI)-driven drug discovery company, to accelerate the discovery of small molecule drugs focused on cardiovascular disease and oncology.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Bayer targets Amazon sellers over fake products

5 September 2023 Healthcare company accuses online sellers of selling unauthorised over-the-counter products | Consumers leave bad reviews after receiving damaged, expired and poor quality goods, says the complaint | Vory, Sater, Seymour and Pease.

Plant Varieties

Rival sues Monsanto, Bayer over GM plant tech

11 August 2022 Firms accused of using GM tech for herbicide-resistant plants | Plaintiff says its patented tech helps farmers to innovate | US District Court for the District of Delaware.

Americas

Bayer to spend up to $4bn on Asklepios BioPharmaceutical

27 October 2020 Germany-based Bayer will pay up to $4 billion to acquire gene therapy company Asklepios BioPharmaceutical.

More on this story

Big Pharma

Bayer targets Amazon sellers over fake products

Plant Varieties

Rival sues Monsanto, Bayer over GM plant tech

11 August 2022 Firms accused of using GM tech for herbicide-resistant plants | Plaintiff says its patented tech helps farmers to innovate | US District Court for the District of Delaware.

Americas

Bayer to spend up to $4bn on Asklepios BioPharmaceutical

27 October 2020 Germany-based Bayer will pay up to $4 billion to acquire gene therapy company Asklepios BioPharmaceutical.

More on this story

Big Pharma

Bayer targets Amazon sellers over fake products

Plant Varieties

Rival sues Monsanto, Bayer over GM plant tech

11 August 2022 Firms accused of using GM tech for herbicide-resistant plants | Plaintiff says its patented tech helps farmers to innovate | US District Court for the District of Delaware.

Americas

Bayer to spend up to $4bn on Asklepios BioPharmaceutical

27 October 2020 Germany-based Bayer will pay up to $4 billion to acquire gene therapy company Asklepios BioPharmaceutical.